Press Release Distribution and Management - Globe Newswire

Lucka 21 - öppna och se - Nordiske Medier Newsroom

BioLamina develops, manufactures and distributes laminins - cell culture reagents intended for culturing of primary cells such BioLamina is a biotechnology company with a global presence, offering cell culture matrices for primary cells. BioLamina General Information Description. Developer of cell culture reagents designed to imitate the natural, cell-specific cell-matrix interaction. The company's reagents provide assistance in culturing of primary cells, preparation of antibiotics, cell development tools, such as stem cells, enabling doctors to improve cell functionality. Biolamina AB was founded in 2008. The company's line of business includes providing commercial physical and biological research and development. SECTOR.

Biolamina

The company's line of business includes providing commercial physical and biological research and development. For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making. Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the biopharma industry and For more information on our products please visit http://www.biolamina.comThis video is an overview of BioLamina AB, a Swedish biotechnology company that dev BioLamina General Information Description. Developer of cell culture reagents designed to imitate the natural, cell-specific cell-matrix interaction. The company's reagents provide assistance in culturing of primary cells, preparation of antibiotics, cell development tools, such as stem cells, enabling doctors to improve cell functionality. We are now recruiting a Sales and Marketing Director to BioLamina, an expanding Swedish biotechnology company with a global presence.

Search Jobs Europass - Europa EU

Biolamina is in the forefront of cell culturing and offers premium high technology products combined with outstanding scientific support. BioLamina was founded in 2008 to supply the world with laminins.

GRID - Global Research Identifier Database

Developer of cell culture reagents designed to imitate the natural, cell-specific cell-matrix interaction. The company's reagents provide assistance in culturing of primary cells, preparation of antibiotics, cell development tools, such as stem cells, enabling doctors to improve cell functionality. Biolamina AB was founded in 2008. The company's line of business includes providing commercial physical and biological research and development. SECTOR.

Read more BioLamina is a Swedish biotechnology company with a global presence, offering cell culture matrices for primary cells. We offer an expansive portfolio of recombinant laminin proteins for a variety Biolamina utvecklar och säljer produkter för cellodling. De innehåller proteiner från lamininfamiljen som finns naturligt i cellers omgivning och som används av Biolamina för att imitera cellernas förhållanden i kroppen. – Jag har haft ögonen på Biolamina ett tag och jag anser att deras produkter är några av de bästa på marknaden för cellapplikationer. Så det ska bli oerhört spännande att fortsätta att bygga Biolaminas försäljning av cellodlingsprodukter globalt, säger Dusan Raicevic i ett pressmeddelande.
Peer learning malmö

1. Bransch.

BioLamina produces cell type specific human recombinant laminins as … BioLamina is a biotechnology company offering cell culture matrices for primary cells. It provides a portfolio of recombinant laminin proteins for a variety of applications, including expansion of pluripotent cell as well as differentiation and maintenance of specialized cell types. Biolamina AB är verksam inom bioteknisk forskning och utveckling och hade totalt 22 anställda 2019. Antalet anställda har ökat med 3 personer sedan 2018 då det jobbade 19 personer på företaget.
Windows 10 systemkrav

judendom
tandtekniker jobb skåne
läsårstider malmö gymnasium
behovsanalys it-system mall
vad är en börs
rehabilitering af ældre
bromolla kommun jobb

Jobb Application Manager 3D - Manpower - Neuvoo

In 2014 several publications including two in the Nature Group showed that the biologically relevant protein for embryonic stem cells, Laminin-521, can be used to proliferate pluripotent cells efficiently in a genetically stable way. Research focus on investigation of laminin-based approaches. Roche (SIX: RO, ROG; OTCQX: RHHBY) and BioLamina, Stockholm, Sweden today announced the signing of a research and development agreement to jointly develop new cell culture systems for various applications, including stem cell research. The collaboration will focus on assessing laminin-based in-vitro cell culture matrices offering 2012 Lund researchers develop new method for producing transplantable cells from stem cells, where the key method is based on laminins from Biolamina. 2012 Lund researchers patent the discovery. 2014 Lund researchers present important data that shows that the dopamine cells produced from stem cells function as well as the cells that are in our brains.